human immunoglobulin G
IgPro20_3007
Phase 3 small_molecule terminated
Quick answer
human immunoglobulin G for Dermatomyositis is a Phase 3 program (small_molecule) at CSL Behring GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CSL Behring GmbH
- Indication
- Dermatomyositis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated